// App-Quantinova.ai

22 : Investigating the functional contribution of TANK binding kinase 1 to inflammation induced disease progression

Researchers

Presenter

  • Victoria H. Burton

Principal Investigators

  • Rolf A. Brekken

Medical Centers

  • UT Southwestern, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Solid malignancies

Biomarkers

  • TANK Binding Kinase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved